SPL Share Price

Open 0.74 Change Price %
High 0.74 1 Day -0.01 -1.33
Low 0.73 1 Week 0.02 2.78
Close 0.74 1 Month -0.10 -11.90
Volume 151226 1 Year 0.14 23.33
52 Week High 0.88
52 Week Low 0.57
SPL Important Levels
Resistance 2 0.75
Resistance 1 0.75
Pivot 0.74
Support 1 0.73
Support 2 0.73
ASX Australia Most Active Stocks
AGO 0.04 0.00%
AGO 0.04 0.00%
AGO 0.04 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
GPP 0.04 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RMI 0.02 100.00%
RMI 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
AZM 0.04 33.33%
AZM 0.04 33.33%
AZM 0.04 33.33%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
ADX 0.01 -50.00%
ADX 0.01 -50.00%
ADX 0.01 -50.00%
NDO 0.04 -33.33%
More..

Starpharma Holdings Ltd (ASX: SPL)

SPL Technical Analysis 1.5
As on 22nd Feb 2017 SPL Share Price closed @ 0.74 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.70 & Sell for SHORT-TERM with Stoploss of 0.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPL Target for February
1st Target up-side 0.85
2nd Target up-side 0.92
3rd Target up-side 0.98
1st Target down-side 0.67
2nd Target down-side 0.6
3rd Target down-side 0.54
SPL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.starpharma.com
SPL Address
SPL
Baker IDI Building
75 Commercial Road
Melbourne, VIC 3004
Australia
Phone: 61 3 8532 2700
Fax: 61 3 9510 5955
SPL Latest News
Starpharma's VivaGel BV granted QIDP status by FDA   Seeking Alpha   - 12th Jan 17
BRIEF-Starpharma signs license for vivagel condom in Iran   Reuters   - 28th Nov 16
Starpharma initiates new DEP™ drug delivery program with AstraZeneca   Nanotechnology News (press release)   - 28th Jul 16
Starpharma: When Will Patience Be Rewarded?   Seeking Alpha   - 14th Jul 16
Australian Team taking Dual Protect™ VivaGel® Condoms to Rio   Australian Olympic Committee   - 16th May 16
Starpharma's VivaGel Effective Against Zika Virus   Seeking Alpha   - 05th May 16
Starpharma Holdings Limited shares soar on breakthrough deal   Motley Fool Australia   - 07th Sep 15
Starpharma Holdings Limited CEO Dr. Jackie Fairley to Be Interviewed Live on ...   Marketwired (press release)   - 13th Feb 15
SPHRY: Starpharma Is Leading the Field With Dendrimers   Investorplace.com   - 06th Jan 15
At 4-year lows and up 19% yesterday: Here's a bargain stock with huge potential   Motley Fool Australia   - 22nd Jul 14
Interactive Technical Analysis Chart Starpharma Holdings Ltd ( SPL ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Starpharma Holdings Ltd
SPL Business Profile
Starpharma Holdings Limited researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia. The company focuses on the development of its topical vaginal microbicide VivaGel as a condom coating for the treatment and prevention of bacterial vaginosis, as well as for the prevention of sexually transmitted infections, including genital herpes and HIV. It is also engaged in exploring dendrimer opportunities in materials science with applications in various areas, such as cosmetics, agrochemicals, and coatings. The company was founded in 1996 and is headquartered in Melbourne, Australia.